• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Key Updates from ASH 2024: Patient Preferences and Shared Decision Making in Hematologic Cancers

home / post-conference-perspectives / key-updates-from-ash-2024-patient-preferences-and-shared-decision-making-in-hematologic-cancers

Sikander Ailawadhi, MD, discusses how significant research data presented at ASH 2024, including advances in targeted therapies, real-world data on patient preferences, and the importance of shared decision-making, are poised to improve treatment outcomes and quality of life for patients with hematologic cancers.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.